| 2024-06-17 | Aerovate Therapeutics, Inc. AVTE | 928,110 0.2418% | $1.67 | $1.55M | -11.52% | |||
| 2024-03-27 | Nkarta, Inc. NKTX | 3M 5.4767% | $10.00 | $30M | -38.48% | |||
| 2024-03-04 | 89bio, Inc. ETNB | 1.35M 1.6718% | $15.35 | $20.72M | -34% | |||
| 2024-02-09 | PepGen Inc. PEPG | 2.56M 10.4935% | $10.64 | $27.21M | -4.57% | |||
| 2024-01-11 | Solid Biosciences Inc. SLDB | 904,160 3.235% | $5.53 | $5M | +16.56% | |||
| 2023-12-11 | Wave Life Sciences Ltd. WVE | 1M 1.2134% | $5.00 | $5M | +26.02% | |||
| 2023-07-21 | Acumen Pharmaceuticals, Inc. ABOS | 5.16M 13.1759% | $7.75 | $40M | -51.11% | |||
| 2023-07-19 | Janux Therapeutics, Inc. JANX | 495,008 1.1638% | $12.46 | $6.17M | -13.34% | |||
| 2023-07-05 | Black Diamond Therapeutics, Inc. BDTX | director | 935,850 2.639% | $5.00 | $4.68M | -26.54% | ||
| 2023-03-24 | 89bio, Inc. ETNB | 2.46M 4.6238% | $16.25 | $40M | -7.38% | |||
| 2023-01-20 | Fulcrum Therapeutics, Inc. FULC | director | 1.92M 3.8009% | $13.00 | $25M | -68.65% | ||
| 2023-01-06 | Werewolf Therapeutics, Inc. HOWL | director | 1.85M 5.9218% | $2.21 | $4.1M | +17.33% | ||
| 2023-01-04 | Fulcrum Therapeutics, Inc. FULC | director | 180,703 0.3049% | $7.28 | $1.31M | -52.11% | ||
| 2022-12-27 | Fulcrum Therapeutics, Inc. FULC | director | 4,089 0.009% | $5.99 | $24,510 | -34.35% | ||
| 2022-12-19 | Fulcrum Therapeutics, Inc. FULC | director | 98,787 0.2145% | $5.90 | $582,814 | -34.35% | ||
| 2022-12-16 | Fulcrum Therapeutics, Inc. FULC | director | 1.34M 3.0203% | $5.42 | $7.27M | -25.98% | ||
| 2022-12-15 | Fulcrum Therapeutics, Inc. FULC | director | 237,029 0.5283% | $5.50 | $1.3M | -27.65% | ||
| 2022-12-14 | Fulcrum Therapeutics, Inc. FULC | director | 824,600 1.8392% | $5.46 | $4.5M | -27.11% | ||
| 2022-10-18 | 89bio, Inc. ETNB | director | 1.17M 2.9627% | $7.65 | $8.97M | +74.54% | ||
| 2022-04-26 | Nkarta, Inc. NKTX | 2.2M 4.4831% | $15.00 | $33M | -27.04% |